Fine Foods & Pharmaceuticals NTM SpA
MIL:FF
Gross Margin
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Peer Comparison
| Country | Company | Market Cap |
Gross Margin |
||
|---|---|---|---|---|---|
| IT |
|
Fine Foods & Pharmaceuticals NTM SpA
MIL:FF
|
229.4m EUR |
Loading...
|
|
| US |
P
|
PerkinElmer Inc
LSE:0KHE
|
1.1T USD |
Loading...
|
|
| US |
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
204.8B USD |
Loading...
|
|
| US |
|
Danaher Corp
NYSE:DHR
|
152.3B USD |
Loading...
|
|
| KR |
|
Samsung Biologics Co Ltd
KRX:207940
|
75.9T KRW |
Loading...
|
|
| CH |
|
Lonza Group AG
SIX:LONN
|
35.6B CHF |
Loading...
|
|
| CN |
|
WuXi AppTec Co Ltd
SSE:603259
|
280B CNY |
Loading...
|
|
| US |
|
Agilent Technologies Inc
NYSE:A
|
37B USD |
Loading...
|
|
| US |
|
IQVIA Holdings Inc
NYSE:IQV
|
30.6B USD |
Loading...
|
|
| US |
|
Mettler-Toledo International Inc
NYSE:MTD
|
28.3B USD |
Loading...
|
|
| US |
|
Waters Corp
NYSE:WAT
|
22.6B USD |
Loading...
|
Market Distribution
| Min | -40 300% |
| 30th Percentile | 38.1% |
| Median | 52.1% |
| 70th Percentile | 67.8% |
| Max | 1 132% |
Other Profitability Ratios
Fine Foods & Pharmaceuticals NTM SpA
Glance View
Fine Foods & Pharmaceuticals N.T.M. The company is headquartered in Verdellino, Bergamo and currently employs 768 full-time employees. The company went IPO on 2016-10-19. The company is specialized in the manufacturing of pharmaceutical products for third parties. The firm manages three segments: Pharmaceuticals, Nutraceuticals and Medical Devices. The Pharmaceuticals segment includes powders and granules, tablets, coated tablets and hard gelatin capsules, packaged in sachets, blisters and bottles. The Nutraceuticals segment includes soluble and effervescent powders and granules, soluble, effervescent and chewable tablets, coated tablets and hard gelatin capsules packaged in bags, sachets, sticks, jars, tablet bottles, blisters and strips. The Medical Devices segment includes tablets, capsules, powders, granules and cover the areas for gastrointestinal, oral and throat treatment and the weight management. Medical Devices marked CE (European Conformity) are available for licensing.
See Also
Gross Margin is calculated by dividing the Gross Profit by the Revenue.
The current Gross Margin for Fine Foods & Pharmaceuticals NTM SpA is 34.8%, which is above its 3-year median of 30.2%.
Over the last 3 years, Fine Foods & Pharmaceuticals NTM SpA’s Gross Margin has increased from 26.4% to 34.8%. During this period, it reached a low of 26.4% on Dec 31, 2022 and a high of 34.8% on Sep 30, 2025.
